Profiling NFκB and VEGF Expression in Mouse Embryonic Stem Cells, Lung Cancer Cells, and Fibroblasts
- 2 September 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 34 (6) , 496-501
Abstract
Cancer is one of the leading causes of morbidity and mortality worldwide, with lung cancer ranked among the most lethal malignancies. A key hallmark of cancer progression is neovascularization, primarily mediated by vascular endothelial growth factor (VEGF), which stimulates vasculogenesis and angiogenesis. In parallel, the transcription factor nuclear factor of kappa B (NFκB) plays a critical role in inflammation, immune regulation, and tumor development by modifying numerous signaling pathways. In this study, we aimed to compare the expression levels of VEGF and NFκB in mouse embryonic stem cells (mESCs), fibroblasts, and lung cancer cells (LCCs) to probe cell-type-specific regulatory profiles. Protein levels were evaluated using immunofluorescence staining and quantified by corrected total cell fluorescence (CTCF), while mRNA expression was analyzed to relate protein-level findings. Our results showed no significant difference in NFκB protein expression among the 3-cell types. In contrast, VEGF protein expression was significantly higher in fibroblasts and lung cancer cells compared with embryonic stem cells. These findings propose that while NFκB may play a stable regulatory role across cell types, VEGF exhibits a dynamic expression pattern linked with angiogenic potential and cellular differentiation status.Keywords
This publication has 22 references indexed in Scilit:
- Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectivesSignal Transduction and Targeted Therapy, 2025
- Nexus of NFκB/VEGF/MMP9 signaling in diabetic retinopathy-linked dementia: Management by phenolic acid-enabled nanotherapeuticsLife Sciences, 2024
- NF-κB in biology and targeted therapy: new insights and translational implicationsSignal Transduction and Targeted Therapy, 2024
- NF-κB: a mediator that promotes or inhibits angiogenesis in human diseases?Expert Reviews in Molecular Medicine, 2023
- Angiogenic signaling pathways and anti-angiogenic therapy for cancerSignal Transduction and Targeted Therapy, 2023
- Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal ComplicationsClinical Lung Cancer, 2015
- NF-κB signaling is activated and confers resistance to apoptosis in three-dimensionally cultured EGFR-mutant lung adenocarcinoma cellsBiochemical and Biophysical Research Communications, 2012
- Enhancement of NF- κ B Expression and Activity Upon Differentiation of Human Embryonic Stem Cell Line SNUhES3Stem Cells and Development, 2007
- Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancerInternational Journal of Cancer, 1999
- KLN205—A murine lung carcinoma cell lineIn Vitro Cellular & Developmental Biology - Plant, 1980